Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Mori, Vyom
- Coronary Artery Calcium Score as a Risk Enhancer in Pre-Diabetics
Abstract Views :201 |
PDF Views:0
Authors
Vyom Mori
1,
Arun Mohanty
2,
Anurag Yadav
2,
Aman Makhija
2,
Bhuwanesh Kandpal
2,
Arjun Sreekumar
2,
J. P. S. Sawhney
2,
R. R. Mantri
2
Affiliations
1 Department of Cardiology, Sir Ganga Ram Hospital, Old Rajinder Nagar, Delhi-110060, IN
2 Department of Cardiology, Sir Ganga Ram Hospital, New Delhi, IN
1 Department of Cardiology, Sir Ganga Ram Hospital, Old Rajinder Nagar, Delhi-110060, IN
2 Department of Cardiology, Sir Ganga Ram Hospital, New Delhi, IN
Source
The Indian Practitioner, Vol 74, No 5 (2021), Pagination: 19-22Abstract
Introduction: Among all the risk factors for atherosclerosis, diabetes is one that has a direct causal association with it, so it has been a focus in major primary prevention studies. The prediabetic population is considered at the same risk as non-diabetics as per the latest guidelines. By using the Coronary artery calcium score (CACS) which is a predictor of cardiovascular events, in this subset of people authors tried to analyse whether prediabetics can be treated the same as non-diabetics. Methods: Patients undergoing CT coronary angiography with no major epicardial coronary artery obstruction were in-cluded and divided into three subgroups of non-diabetic, pre-diabetic and diabetic. Their CACS were measured and compared for any significance. Results: A total of 300 patients were part of the study with 100 patients in each subgroup. The mean age of the population was 48 years. Lipid profile was significantly deranged in the non-diabetic and pre-diabetic subgroup as they were not on any therapy. CACS was 5.4 ± 37.37, 98.02 ± 300.89, 209.47 ± 277.61 in non-diabetic, pre-diabetic and diabetic subgroups respectively. The CACS was much higher in the pre-diabetic subgroup of people missing statistical significance by only a small margin. Conclusion: From this observational study authors conclude that prediabetics are at much higher risk of adverse cardio-vascular events than non-diabetics and so when it comes to primary prevention therapy, they should not be considered in the same risk category as non-diabetics.Keywords
Primary prevention; risk modifier; atherosclerosis.
References
- Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al; ESC Scientific Document Group. 2019 ESC/ EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J.2020;41(1):111-188.
- Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Circulation. 2019;140(11):e596-e646.
- Vliegenthart R, Oudkerk M, Hofman A, Oei HH, van Dijck W, van Rooij FJ, et al. Coronary calcification improves cardiovascular risk prediction in the elderly. Circulation. 2005;112(4):572-7.
- Yano Y, O’Donnell CJ, Kuller L, Kavousi M, Erbel R, Ning H, et al. Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies. JAMA Cardiol.2017;2(9):986-994.
- Kavousi M, Desai CS, Ayers C, Blumenthal RS, Budoff MJ, Mahabadi AA, et al. Prevalence and Prognostic Implications of Coronary Artery Calcification in Low-Risk Women: A Meta-analysis. JAMA. 2016;316(20):2126-2134.
- Raggi P, Callister TQ, Shaw LJ. Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy. Arterioscler Thromb Vasc Biol. 2004;24(7):1272-7.
- Budoff MJ, Young R, Lopez VA, Kronmal RA, Nasir K, Blumenthal RS, et al. Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2013;61(12):12319.
- Budoff MJ, Hokanson JE, Nasir K, Shaw LJ, Kinney GL, Chow D, et al. Progression of coronary artery calcium predicts allcause mortality. JACC Cardiovasc Imaging. 2010;3(12):122936.
- Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al; ESC Scientific Document Group. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255-323.
- Maki KC, Diwadkar-Navsariwala V, Kramer MW. Statin use and risk for type 2 diabetes: what clinicians should know. Postgrad Med. 2018;130(2):166-172.
- A Rare Case of Transient High-grade AV Block due to Covid-19
Abstract Views :143 |
PDF Views:0
Authors
Affiliations
1 Department of Cardiology, Sir Ganga Ram Hospital, New Delhi-110060, IN
1 Department of Cardiology, Sir Ganga Ram Hospital, New Delhi-110060, IN
Source
The Indian Practitioner, Vol 74, No 9 (2021), Pagination: 30-32Abstract
The involvement of various systems with Covid-19 manifestation ranging from asymptomatic to sudden cardiac arrest have been reported. Cardiovascular complications are the most dreadful ones as they can lead to further decompensation of patient and decrease the chances of recovery. Arrhythmic tendencies increase with the severity of covid illness. More frequently are the tachyarrhythmias including atrial fibrillation, sinus tachycardia and ventricular ectopic. We report such a case of covid induced high-grade atrioventricular block that was transient with spontaneous recovery after the waiting period.Keywords
Covid-19, AV block, spontaneous recoveryReferences
- World Health Organization. Coronavirus Disease (COVID-19) Situation Reports. https://www.who.int/docs/ default-source/coronaviruse/ situation-reports/20200404- sitrep75-covid-19.pdf?sfvrsn=99251b2b_2. Accessed April 5, 2020.
- Fried JA, Ramasubbu K, Bhatt R, Topkara VK, Clerkin KJ, Horn E, Rabbani L, Brodie D, Jain SS, Kirtane A, et al. The variety of cardiovascular presentations of COVID-19. Circulation. 2020;141:1930–1936.
- Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–1069.
- Lakkireddy DR, Chung MK, Gopinathannair R, Patton KK, Gluckman TJ, Turagam M, Cheung J, Patel P, Sotomonte J, Lampert R, et al. Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association. Circulation. 2020;141:e823– e831.
- Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242.
- Azarkish M, Laleh Far V, Eslami M, Mollazadeh R. Transient complete heart block in a patient with critical COVID-19. Eur Heart J.2020;41:2131.
- El Assaad I, Hood-Pishchany MI, Kheir J, Mistry K, Dixit A, Halyabar O, et al. Complete heart block, severe ventricular dysfunction and myocardial inflammation in a child with COVID-19 infection. JACC Case Rep 2020. PII:S26660849(20)30486- 1.
- Gopinathannair R, Merchant FM, Lakkireddy DR, Etheridge SP, Feigofsky S, Han JK, et al. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J Interv Card Electrophysiol. 2020;1–8.
- Basu-Ray I, NkAlmaddah, Adeboye A, Soos MP. Cardiac manifestations of coronavirus (COVID-19). StatPearls 2020;(April).
- Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A. Myocardial injury and COVID-19: possible mechanisms. Life Sci.2020;253:117723.
- Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med.2020;8:420–2.
- Tse G, Yeo JM, Chan YW, Lai ETH, Yan BP. What is the arrhythmic substrate in viral myocarditis? Insights from clinical and animal studies. Front Physiol.2016;7:308.
- Al-Assaf O, Mirza M, Musa A. Atypical presentation of COVID-19 as subclinical myocarditis with persistent highdegree atrioventricular block treated with pacemaker implant. HeartRhythm Case Rep. 2020 Nov;6(11):884-887.